For debate: are we ready for GAD-vaccination in the treatment and/or prevention of type 1 diabetes?
Ludvigsson
Johnny
J
Div of Pediatrics and Diabetes Research Centre, Dept of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. Johnny.Ludvigsson@lio.se
D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy*; D005968:Glutamate Decarboxylase / Q000276:immunology*; D006801:Humans; D014612:Vaccines / Q000627:therapeutic use*
D014612:Vaccines; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2